Format

Send to

Choose Destination
Can J Cardiol. 2017 Sep;33(9):1201-1205. doi: 10.1016/j.cjca.2017.05.018. Epub 2017 May 30.

Adult Congenital Heart Disease Intervention: The Canadian Landscape.

Author information

1
Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
2
Institut de Cardiologie de Montréal, Montréal, Canada.
3
St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
4
Southlake Regional Health Centre, University of Toronto, Toronto, Ontario, Canada.
5
Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.
6
Centre Hospitalier de l'Université de Montréal, Montréal, Canada.
7
Department of Cardiac Science, Royal Columbian Hospital, New Westminster, British Columbia, Canada.
8
Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
9
Dalhousie University, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.
10
Centre for Heart Valve Innovation, St Paul's and Vancouver General Hospital, Vancouver, British Columbia, Canada.
11
The Canadian Association of Interventional Cardiology, Halifax, Nova Scotia, Canada.
12
Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Toronto General Hospital, Toronto, Ontario, Canada. Electronic address: eric.horlick@uhn.ca.

Abstract

Once considered a childhood disease, the number of adults living with congenital heart disease (CHD) has now exceeded the number of pediatric patients. The landscape of percutaneous intervention for adult congenital heart disease (ACHD) has evolved over the past decade and has yet to be characterized in Canada. The aim of this study was to begin to understand the current infrastructure underlying ACHD interventions in Canada and to characterize the type and number of interventions being carried out across the country. A cross-sectional national survey was distributed by e-mail to all cardiac catheterization laboratory directors in 2015. All Canadian laboratories involved in ACHD interventions responded, encompassing 19 institutions spanning 69 cardiac catheterization laboratories. A total of 1451 percutaneous interventions were recorded. Nationwide, the most common simple ACHD interventions were for atrial septal defect and patent foramen ovale closures. The most common ACHD interventions of increased complexity were for coarctation stenting and transcatheter pulmonary valve implantation. There was a marked clustering of procedures in Ontario, Québec, British Columbia, and Alberta in keeping with Canada's population-density distribution. A total of 23 ACHD operators were identified, half of whom had ACHD-specific fellowship training. These data can be used as a starting point to inform the present state of affairs in the area and lay the groundwork for further work to assess resource allocation and human resource planning for the care of patients with ACHD in Canada.

PMID:
28843330
DOI:
10.1016/j.cjca.2017.05.018
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center